Sign in
4

Changes in Ownership

Definium Therapeutics, Inc. Filed Acc 0001209191-22-018614

VP, Controller&Acct Principal acquired 403,430 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Liao Carrie VP, Controller&Acct Principal 2022-02-10 Grant or award +403,430 403,430 D
Derivatives
Liao Carrie VP, Controller&Acct Principal 2022-02-10 Grant or award · Stock Option (Right to Buy) +524,450 524,450 D
Loading xslF345X03/doc4.xml…